Apotheca Biosciences Stock Forecast, Price & News

0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
Today's Range
Now: $0.08
50-Day Range
MA: $0.07
52-Week Range
Now: $0.08
Volume2,400 shs
Average Volume45,056 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Apotheca Biosciences, Inc. engages in the development of cutting-edge medical products, nutraceuticals, formulation and delivery technologies for the healthcare and consumer care industries. Its products include transdermal, sublingual, and nasal delivery technologies for precise and controlled dosing of cannabinoids. The company was founded on October 6, 2014 and is headquartered in St. Petersburg, FL.

Industry, Sector and Symbol

Industry Packaged Foods
Current SymbolOTCMKTS:PCFP
Phone(727) 228-3994
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.64 out of 5 stars

Consumer Defensive Sector

39th out of 159 stocks

Packaged Foods Industry

13th out of 42 stocks

Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PCFP News and Ratings via Email

Sign-up to receive the latest news and ratings for PCFP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Apotheca Biosciences (OTCMKTS:PCFP) Frequently Asked Questions

What stocks does MarketBeat like better than Apotheca Biosciences?

Wall Street analysts have given Apotheca Biosciences a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Apotheca Biosciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Apotheca Biosciences' stock price been impacted by COVID-19 (Coronavirus)?

Apotheca Biosciences' stock was trading at $0.0190 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PCFP shares have increased by 294.7% and is now trading at $0.0750.
View which stocks have been most impacted by COVID-19

Who are Apotheca Biosciences' key executives?

Apotheca Biosciences' management team includes the following people:
  • Saed Talari, President & Chief Financial Officer
  • Karin Rohret, Secretary
  • Craig A. Huffman, Head-Legal Counsel

Who are some of Apotheca Biosciences' key competitors?

What other stocks do shareholders of Apotheca Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apotheca Biosciences investors own include Cronos Group (CRON), SMART Global (SGH), America First Multifamily Investors (ATAX), Jumia Technologies (JMIA), (SCP.TO) (SCP), Tilray (TLRY), Allena Pharmaceuticals (ALNA), (CGC), General Electric (GE) and Kinder Morgan (KMI).

What is Apotheca Biosciences' stock symbol?

Apotheca Biosciences trades on the OTCMKTS under the ticker symbol "PCFP."

How do I buy shares of Apotheca Biosciences?

Shares of PCFP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Apotheca Biosciences' stock price today?

One share of PCFP stock can currently be purchased for approximately $0.08.

What is Apotheca Biosciences' official website?

The official website for Apotheca Biosciences is www.cannabisleafinc.co.

How can I contact Apotheca Biosciences?

The company can be reached via phone at (727) 228-3994.

This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.